Athersys (ATHX), Initiates Phase II Trial in Inflammatory Bowel Disease
March 14th, 2011
No comments
ATHX and Pfizer (PFE) collaborate on Stem Cell Therapy for Ulcerative Colitis (UC) Read more…
Categories: Initiation Phase II Trial, NASDAQ: ATHX, Stem Cell Research
